Current role
Biotechnology · Healthcare
Board Member
2026-05-20–present
Joshua Mandel-Brehm
Board Member
ProMIS Neurosciences Inc. (PMN)Equibles does not estimate personal net worth.
Get an email with a short summary when ProMIS Neurosciences Inc. publishes a filing, an earnings call transcript or a press release.
Get PMN alertsAbout Joshua Mandel-Brehm
Joshua Mandel-Brehm is recorded as Board Member at ProMIS Neurosciences Inc. (PMN) since May 20, 2026. ProMIS Neurosciences Inc. reported in an 8-K filed May 20, 2026 that Joshua Mandel-Brehm was appointed director, effective May 20, 2026. ProMIS Neurosciences Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at ProMIS Neurosciences Inc. includes Gail Farfel (CEO), Gail M. Farfel (CEO), Gail M. Farfel, PhD (CEO) and 7 others.
“All seven nominees were elected.”
Affiliation history
-
Current
2026-05-20–present
Company network
Leadership on record at ProMIS Neurosciences Inc.
- Gail Farfel CEO
- Gail M. Farfel CEO
- Gail M. Farfel, PhD CEO
- Neil Warma CEO, Board Member
- Bill Wyman Board Member
- Eugene Williams Board Member
- Josh Mandel-Brehm Board Member
- Maggie Shafmaster Board Member
- Maggie Shafmaster, Ph.D,J.D. Board Member
- Maggie Shafmaster, Ph.D., J.D. Board Member